Form 8-K - Current report:
SEC Accession No. 0001193125-25-141098
Filing Date
2025-06-16
Accepted
2025-06-16 07:30:24
Documents
14
Period of Report
2025-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d13247d8k.htm   iXBRL 8-K 24739
2 EX-99.1 d13247dex991.htm EX-99.1 13097
6 GRAPHIC g13247g0614105658497.jpg GRAPHIC 3997
  Complete submission text file 0001193125-25-141098.txt   165642

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prta-20250615.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20250615_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20250615_pre.xml EX-101.PRE 11688
17 EXTRACTED XBRL INSTANCE DOCUMENT d13247d8k_htm.xml XML 3833
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 251048534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)